Biohm Technologies
Douglas Weintraub is an experienced investor and board member involved in multiple ventures across various industries. Currently, Weintraub serves as an investor for Corner Provisions, ScriptDrop, Hearty, BIOHM Health, The Creswell, 2320 Lofts, Fiducius, and Oasis Consumer Healthcare. In addition, Weintraub holds the position of strategic advisor at Green Egg Ventures and has been influential in shaping the direction of Guiding Group / Learnmap. With a Bachelor of Science in Accounting and Computer Science from The Ohio State University Fisher College of Business, earned between 1978 and 1982, Weintraub possesses a strong educational background complementing extensive involvement in real estate and health sectors.
This person is not in the org chart
This person is not in any teams
Biohm Technologies
Biohm Technologies, based in Cleveland, OH, specializes in the development of targeted microbiome products leveraging the company’s extensive dataset of bacterial and fungal populations in the gut, a departure from the industry's predominant focus on bacteria alone. Biohm’s data-driven methodology, called Symbiont™, is the basis for the creation of award-winning ingredients validated through clinical trials. The company’s flagship ingredient is Mycohsa™, the first data-powered probiotic blend clinically shown to break down digestive biofilms and support optimal levels of both bacteria and yeasts for gut health. Biohm Technologies also offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space.